Overall survival in the OlympiA trial

Overall survival in the OlympiA trial

OVERVIEW OlympiA demonstrates statistically significant improvement in overall survival with adjuvant olaparib compared with placebo TITLE OF PUBLICATION Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants...